帕金森病言语障碍特征性表现及干预治疗研究进展

阳杨;庞子建;高立群;

1:北京语言大学语言康复学院

摘要
<正>帕金森氏病(Parkinson disease,PD)是一种退行性脑神经疾病,呈慢性进展性,英国医生James Parkinson于1817年在其书《An Essay on the Shaking Palsy》中首次讲述了PD的相关症状,除肢体运动障碍外,多次明确阐述了言语受损(speech interrupt)问题。至2015年,全世界的PD患者达620万([1]),一项由Zhang等(2005)的横断面研究显示,我国的PD患病率(prevalence)与发达国家相似,
关键词
基金项目(Foundation):
作者
阳杨;庞子建;高立群;
参考文献

1 Kalia LV,Lang AE.Parkinson’s disease[J].The Lancet,2015,386(9996):896-912.

2 Duffy JR.Motor speech cisorders:substrates,differential diagnosis,and management[M].St Louis:MO:Elsevier,2013.11,430,262.

3 Defazio G,Guerrieri M,Liuzzi D,et al.Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile[J].Neurol Sci,2016,37(3):443-449.

4 Yang S,Wang F,Yang L,et al.The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinsoé s disease[J].Scientific Reports,2020,10(1):1-9.

5 Rusz J,Cmejla R,Tykalova T,et al.Imprecise vowel articulation as a potential early marker of Parkinson’s disease:effect of speaking task[J].J Acoust Soc Am,2013,134(3):2171-2181.

6 Abur D,Lupiani A,Hickox A,et al.Loudness perception of pure tones in parkinson’s disease[J].Journal of Speech,Language,and Hearing Research,2018,61(6):1-10.

7 Huang X,Chen X,Yan N,et al.The impact of parkinson’s disease on the cortical mechanisms that support auditory-motor integration for voice control[J].Human Brain Mapping,2016,37(12):4248-4261.

8 Mollaei F,Shiller DM,Baum SR,et al.Sensorimotor control of vocal pitch and formant frequencies in Parkinson’s disease[J].Brain Research,2016,1646:269-277.

9 Aldridge D,Theodoros D,Angwin A,et al.Speech outcomes in Parkinson’s disease after subthalamic nucleus deep brain stimulation:a systematic review[J].Parkinsonism Relat Disord,2016,33:3-11.

10 Abeyesekera A,Adams S,Mancinelli C,et al.Effects of deep brain stimulation of the subthalamic nucleus settings on voice quality,intensity,and prosody in parkinson’s disease:preliminary evidence for speech optimization[J].Can J Neurol Sci,2019,46(3):287-294.

11 Yorkston KM,Beukelman DR,Strand EA,et al.Management of motor speech disorders in children and adults[M].3rd.Austin,Texas:Pro-Ed,2010.435-515.

12 Tjaden K,Sussman JE,Wilding GE.Impact of clear,loud,and slow speech on scaled intelligibility and speech severity in Parkinson’s disease and multiple sclerosis[J].J Speech Lang Hear Res,2014,57(3):779-792.

13 Mcauliffe MJ,Kerr SE,Gibson EM,et al.Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria[J].J Speech Lang Hear Res,2014,57(4):1268-1283.

14 Griffin M,Bentley J,Shanks J,et al.The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device:a non-inferiority study[J].Journal of Telemedicine and Telecare,2018,24(3):245-248.

15 李咏雪,谭茗丹,范豪,等.励-协夫曼言语治疗对中国帕金森病患者言语功能的影响[J].中华物理医学与康复杂志,2020,42(3):245-248.

16 杨美芳,赵健,且亚玲,等.励-协夫曼言语治疗对帕金森病患者言语功能及生活质量的影响[J].中华物理医学与康复杂志,2017,39(1):43-47.

17 Narayana S,Fox PT,Zhang W,et al.Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis[J].Hum Brain Mapp,2010,31(2):222-236.

18 Baumann A,Nebel A,Granert O,et al.Neural correlates of hypokinetic dysarthria and mechanisms of effective voice treatment in parkinson disease[J].Neurorehabil Neural Repair,2018,32(12):1055-1066.

19 Chae HR,Choi SH,Choi CH,et al.Effects of lax vox voice therapy on respiration and phonation in patients with Parkinson’s disease[J].Commun Sci Disord,2019,24(3):785-799.

20 Ramig L,Halpern A,Spielman J,et al.Speech treatment in Parkinson’s disease:Randomized controlled trial (RCT)[J].Mov Disord,2018,33(11):1777-1791.

21 Levy ES,Moya-Galé G,Chang YHM,et al.The effects of intensive speech treatment on intelligibility in Parkinson’s disease:a randomised controlled trial[J].EClinical Medicine,2020,24:100429.

22 Brabenec L,Klobusiakova P,Barton M,et al.Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson’s disease[J].Parkinsonism Relat Disord,2019,61:187-192.

23 Ateras B,Piekartz HV.Integration of a neurodynamic approach into the treatment of dysarthria for patients with idiopathic Parkinson’s disease:a pilot study[J].Journal of Bodywork and Movement Therapies,2018,22(3):648-656.

24 Sauvageau VM,Roy JP,Langlois M,et al.Impact of the LSVT on vowel articulation and coarticulation in Parkinson’s disease[J].Clin Linguist Phon,2015,29(6):424-440.

25 Whitehill TL,Kwan L,Lee FP,et al.Effect of LSVT on lexical tone in speakers with parkinson’s disease[J].Parkinsons Dis,2011,2011:1-10.

26 Pinto S,Chan A,Guimar?es I,et al.A cross-linguistic perspective to the study of dysarthria in Parkinson’s disease[J].Journal of Phonetics,2017,64:156-167.

本文信息

PDF(1445K)

本文关键词相关文章

本文作者相关文章

阳杨庞子建高立群